Evidence map›Paper›PMID 24141989›Full record

ArticleHeart and vessels2014

Cardioprotective effects of adipokine apelin on myocardial infarction.

Bao-Hai Zhang, Cai-Xia Guo, Hong-Xia Wang, Ling-Qiao Lu, Ya-Jie Wang, Li-Ke Zhang, Feng-He Du, Xiang-Jun Zeng

Abstract read
PubMed Publisher
In one paragraph

Article in Heart and vessels, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
4.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 53 citations in OpenAlex.

  1. Apelin - A New Kid on the Block in Periodontology.Oral health & preventive dentistry · 2024
    Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Serum apelin levels and cardiovascular diseases.Northern clinics of Istanbul · 2022
    Review
  8. Identification of 6-Hydroxypyrimidin-4(1ACS medicinal chemistry letters · 2021
    Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Apelinergic System Structure and Function.Comprehensive Physiology · 2017
    Review
  17. Observational
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Bao-Hai ZhangThe Department of Pathophysiology, Capital Medical University, Beijing, 100069, China.
Cai-Xia Guo
Hong-Xia Wang
Ling-Qiao Lu
Ya-Jie Wang
Li-Ke Zhang
Feng-He Du
Xiang-Jun Zeng
Capital Medical University · CNCapital University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Angiogenesis plays an important role in myocardial infarction. Apelin and its natural receptor (angiotensin II receptor-like 1, AGTRL-1 or APLNR) induce sprouting of endothelial cells in an autocrine or paracrine manner. The aim of this study is to investigate whether apelin can improve the cardiac function after myocardial infarction by increasing angiogenesis in infarcted myocardium. Left ventricular end-diastolic pressure (LVEDP), left ventricular end systolic pressure (LVESP), left ventricular developed pressure (LVDP), maximal left ventricular pressure development (±LVdp/dtmax), infarct size, and angiogenesis were evaluated to analyze the cardioprotective effects of apelin on ischemic myocardium. Assays of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, 5-bromo-2'-deoxyuridine incorporation, wound healing, transwells, and tube formation were used to detect the effects of apelin on proliferation, migration, and chemotaxis of cardiac microvascular endothelial cells. Fluorescein isothiocyanate-labeled bovine serum albumin penetrating through monolayered cardiac microvascular endothelial cells was measured to evaluate the effects of apelin on permeability of microvascular endothelial cells. In vivo results showed that apelin increased ±LV dp/dtmax and LVESP values, decreased LVEDP values (all p < 0.05), and promoted angiogenesis in rat heart after ligation of the left anterior descending coronary artery. In vitro results showed that apelin dose-dependently enhanced proliferation, migration, chemotaxis, and tube formation, but not permeability of cardiac microvascular endothelial cells. Apelin also increased the expression of vascular endothelial growth factor receptors-2 (VEGFR2) and the endothelium-specific receptor tyrosine kinase (Tie-2) in cardiac microvascular endothelial cells. These results indicated that apelin played a protective role in myocardial infarction through promoting angiogenesis and decreasing permeability of microvascular endothelial cells via upregulating the expression of VEGFR2 and Tie-2 in cardiac microvascular endothelial cells.

Indexed as

Angiogenesis Inducing AgentsAnimalsCapillary PermeabilityCardiotonic AgentsCell ProliferationCells, CulturedChemotaxisDisease Models, AnimalDose-Response Relationship, DrugEndothelial CellsIntercellular Signaling Peptides and ProteinsMaleMyocardial InfarctionMyocardiumNeovascularization, PhysiologicRats, WistarAngiogenesis Inducing Agentsapelin-13 peptideCardiotonic AgentsIntercellular Signaling Peptides and ProteinsReceptor, TIE-2Vascular Endothelial Growth Factor Receptor-2

Identifiers

PMID24141989
OpenAlexW1994608550

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.